ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 145 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $18,293,000 | +64.6% | 969,950 | +2.7% | 0.00% | +33.3% |
| Q2 2019 | $11,114,000 | -6.2% | 944,344 | +8.8% | 0.00% | 0.0% |
| Q1 2019 | $11,850,000 | -10.8% | 868,135 | -33.1% | 0.00% | +50.0% |
| Q4 2018 | $13,292,000 | +28.9% | 1,296,880 | +109.5% | 0.00% | -33.3% |
| Q3 2018 | $10,308,000 | +9.4% | 619,144 | +3.9% | 0.00% | 0.0% |
| Q2 2018 | $9,418,000 | +29.9% | 596,126 | +4.4% | 0.00% | +50.0% |
| Q1 2018 | $7,249,000 | +13.1% | 570,789 | +2.0% | 0.00% | 0.0% |
| Q4 2017 | $6,410,000 | +1.4% | 559,850 | +8.5% | 0.00% | 0.0% |
| Q3 2017 | $6,320,000 | +32.4% | 515,986 | +23.8% | 0.00% | 0.0% |
| Q2 2017 | $4,773,000 | -42.9% | 416,893 | +3.8% | 0.00% | -33.3% |
| Q1 2017 | $8,352,000 | +21.4% | 401,570 | +21.4% | 0.00% | 0.0% |
| Q4 2016 | $6,882,000 | -35.7% | 330,879 | +1.3% | 0.00% | -40.0% |
| Q3 2016 | $10,706,000 | +31.3% | 326,726 | +0.1% | 0.01% | +25.0% |
| Q2 2016 | $8,152,000 | +85.7% | 326,473 | +82.1% | 0.00% | +100.0% |
| Q1 2016 | $4,389,000 | -24.3% | 179,237 | +2.1% | 0.00% | -33.3% |
| Q4 2015 | $5,800,000 | -4.3% | 175,616 | -5.1% | 0.00% | -25.0% |
| Q3 2015 | $6,061,000 | -6.9% | 185,041 | +50.6% | 0.00% | 0.0% |
| Q2 2015 | $6,509,000 | +109.0% | 122,897 | +13.9% | 0.00% | +100.0% |
| Q1 2015 | $3,114,000 | +103.1% | 107,911 | +104.7% | 0.00% | +100.0% |
| Q4 2014 | $1,533,000 | +211.0% | 52,727 | +35.4% | 0.00% | – |
| Q3 2014 | $493,000 | -36.6% | 38,942 | +0.5% | 0.00% | -100.0% |
| Q2 2014 | $777,000 | – | 38,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |